Searched for
ELI LILLY TRILLION MARKET CAP
Dow Jones hits record above 52,000 as Alphabet debuts in index, S&P 500 climbs and Nasdaq jumps over 2% as tech stocks lead Wall Street rally - here's how US stock market performed today (June 29)S&P 500, Dow Jones and Nasdaq today June 29: The US stock market started the shortened trading week with solid gains as the Dow Jones close...- NSE IPO to value exchange at Rs 5 lakh crore? 2 scenarios every investor should watchNSE's proposed IPO could value the exchange at around Rs 5 lakh crore, making it one of India's most valuable listed financial institutions...
- South Korea’s favourite AI stocks slide again, drag Kospi index down 8%Heavyweights Samsung Electronics and SK Hynix, which together account for more than half of Kospi's market cap, fell around 9% each on Frid...
- South Korean stocks in tailspin as Kospi crashes 8%, head for worst week since MarchSouth Korean stocks experienced a dramatic plunge, exceeding 8% and triggering a trading halt. This sharp decline was primarily driven by a...
- Centre set to tighten oversight of pharma packaging materialsIndia is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...
- Eli Lilly launches cancer drug Tanstrive in IndiaThe launch follows marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for patients with locally advanced ...
- Oil, AI and chips: The new resource race redrawing markets and nationsThe leap to a $5 trillion valuation for Nvidia underscores a dramatic paradigm shift: semiconductors have become the driving force of globa...
- SpaceX shares extend slide with another 3% fall; over $600 billion in market value wiped out in 3 sessionsSpaceX shares fell another 3%, extending a three-day selloff that has wiped out over $600 billion in market value and pushed the stock belo...
- Elon Musk's fortune takes a $300 billion hit as SpaceX sees $1 trillion rout in market valueElon Musk's net worth has dropped by an estimated $350 billion after SpaceX shares tumbled more than 30% from their post-IPO peak, wiping o...
- Jio Platforms' debut could give RIL top 2 slots in Indian m-cap leagueMukesh Ambani's Reliance group is set to significantly boost its market presence, potentially holding nearly 7% of BSE's total market capit...
- Green economy companies top $10 trillion market capThe green economy has hit a record $10 trillion market value. Revenue from climate solutions grew significantly last year. Companies focuse...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...
- India's Electronics Mart eyes new markets as tech hubs fear job lossesElectronics Mart India is diversifying its store presence beyond Hyderabad due to concerns about potential AI-driven job losses impacting c...
- Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...
- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- UK approves Novo weight-loss pill to edge open European marketBritain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...
- US stocks: Musk's SpaceX prices record $75 billion IPO at $135 a shareSpaceX has priced its record-breaking U.S. IPO at $135 per share, raising $75 billion and valuing the company at $1.77 trillion. This makes...
- US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss marketLilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...
- Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefitsEli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...
Load More
